Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Breaking News: Technology Alphabet Inc Eli Lilly and Co
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Health care industry Labor economy
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Novo Nordisk A/S Biotechnology Business
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Investing stocks Eli Lilly and Co
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Breaking News: Technology Internet Hospitals
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Biotechnology Business Companies
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags S&P 500 Arista Networks Inc Market Outlook
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Fusion Pharmaceuticals Inc Novartis AG AstraZeneca PLC
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Eli Lilly and Co Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Health care industry Companies Health & Science
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Alphabet Inc Science Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Biotech and Pharmaceuticals Social issues Novo Nordisk A/S
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Alphabet Inc Technology Breaking News: Technology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Apple Inc Healthy Returns Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Viking Therapeutics Inc Altimmune Inc Biotech and Pharmaceuticals
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Pharmaceuticals AI / Artificial Intelligence Medicine
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Tags Biotech and Pharmaceuticals Europe Markets Eli Lilly and Co
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Business News Business Biotechnology
From CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Tags Pharmaceuticals US: News Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Block Inc Qualcomm Inc Apple Inc
From CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
Tags Markets stocks Apple Inc
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Food Retail Molson Coors Beverage Co Health care industry
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Health & Science Companies Health care industry
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Health care industry Health & Science Companies
From CNBC.com News
Cramer says stocks that pulled back Tuesday still 'have everything going for them'
Tags stocks Eli Lilly and Co Investing
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Business News Biotechnology Business
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Novo Nordisk A/S Health care industry Health & Science
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Business News Science Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.